Castle has flat (not decreasing) sales, $18 million (positive) in working capital, $30 million invested last year and still only sells for around one times sales.
It's a perfect example of what can happen to a company that lets SG&A get out of hand (though it's SG&A is only about equal to its sales, last quarter, DKAM's was 3 times as large as it's sales).
It trades on the Amex. Remember too, ROX was at $6 2 years ago, today it's at 21 cents.
So again, it's only my opinion, but I think things could be much worse for DKAM.
News 
Market Data 
Discover 
